Evidence map›Paper›PMID 22236000›Full record

ArticleClinical and experimental immunology2012

Galectin-3 in cord blood of term and preterm infants.

M Demmert, K Faust, M K Bohlmann, B Tröger, W Göpel, E Herting, C Härtel

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Clinical and experimental immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Galectins: Important Regulators in Normal and Pathologic Pregnancies.International journal of molecular sciences · 2022
    Review
  4. Galectins in Early Pregnancy and Pregnancy-Associated Pathologies.International journal of molecular sciences · 2021
    Review
  5. Review
  6. Article
  7. Article
  8. Antifungal Immunological Defenses in Newborns.Frontiers in immunology · 2017
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

M DemmertDepartment of Paediatrics, University of Lübeck, Lübeck, Germany.
K Faust
M K Bohlmann
B Tröger
W Göpel
E Herting
C Härtel
University of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years galectin-3 has gained attention as a signalling molecule, mainly in inflammatory diseases. Data on galectin-3 expression in neonates, however, are limited, and expression of this lectin in cord blood has not yet been reported. The aim of this study was to determine galectin-3 levels in cord blood of term and preterm neonates as well as galectin-3 levels in cord blood of term neonates after stimulation with the prevalent pathogen Streptococcus agalactiae. Cord blood samples were incubated for 24 h and galectin-3 levels were assessed by enzyme-linked immunosorbent assay. There is a positive correlation between gestational age and galectin-3 levels in cord blood. Expression of galectin-3 is significantly higher in cord blood of small-for-gestational-age infants compared to appropriate-for-gestational-age infants. Stimulation with an invasive but not with a colonizing strain of S. agalactiae induced expression of galectin-3. Galectin-3 is expressed constitutively in cord blood of neonates and seems to play a role in the innate immunity of this population.

Indexed as

Birth WeightBlood CellsCells, CulturedEthnicityFemaleFetal BloodFetal Growth RetardationGalectin 3GermanyGestational AgeHumansImmunity, InnateInfant, NewbornInfant, PrematureInfant, Small for Gestational AgeMaleGalectin 3

Identifiers

PMID22236000
PMCPMC3278690
OpenAlexW1509352806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.